# Revisiting Minamata disease through computational phenotypic similarity analysis

**Authors:** Edoardo Marchi, Paolo Boldi, Elena Casiraghi, Stefano Zapperi, Caterina A. M. La Porta, Nikolas Pontikos, Ejaz Khan, Ejaz Khan, Ejaz Khan

PMC · DOI: 10.1371/journal.pone.0342655 · PLOS One · 2026-02-26

## TL;DR

This study uses modern computational methods to analyze the symptoms of Minamata disease and find connections to other neurological disorders.

## Contribution

The study introduces a network-based approach to analyze Minamata disease's phenotypic profile and compare it with thousands of other diseases.

## Key findings

- Minamata disease shows strong phenotypic similarity to movement and neurodegenerative disorders like cyanide-induced parkinsonism.
- Computational analysis revealed a robust consensus network of diseases with overlapping symptoms.
- The study demonstrates how historical data can be integrated with modern tools to explore environmental disease mechanisms.

## Abstract

Minamata disease, a severe neurological disorder caused by methylmercury exposure in 1950s Japan, is historically recognized for its profound impact on environmental health awareness. However, its phenotypic complexity and potential overlap with other neurological disorders have not been systematically assessed in a modern computational framework. In this study, we adopt a network approach to reinterpret Minamata disease within a broader disease similarity landscape. We mapped clinical symptoms from an extensive epidemiological survey of 269 Minamata patients to standardized Human Phenotype Ontology (HPO) terms, constructing a comprehensive phenotypic profile. Using network-based and computational similarity measures—Jaccard Index, ontology-informed metrics (Resnik and GraphIC), and information retrieval techniques (TF-IDF with query expansion), we compared this profile to over 12,000 diseases. Our results consistently identified strong phenotypic ties between Minamata disease and several movement and neurodegenerative disorders, including cyanide-induced parkinsonism and progressive supranuclear palsy. A weighted rank aggregation across methods revealed a robust consensus network of diseases with overlapping symptomatology, underscoring the systemic nature of these complex neurological disorders. Our study highlights the utility of integrating historical epidemiological data with contemporary network tools to reveal novel associations between environmental exposures and systemic pathophysiological responses. Our findings provide a blueprint for exploring environmentally triggered disease mechanisms and their broader implications for network-based understanding of human disease.

## Linked entities

- **Chemicals:** methylmercury (PubChem CID 6860)
- **Diseases:** Minamata disease (MONDO:0024251), cyanide-induced parkinsonism (MONDO:0017640), progressive supranuclear palsy (MONDO:0019037)

## Full-text entities

- **Genes:** F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, PRKAR1B (protein kinase cAMP-dependent type I regulatory subunit beta) [NCBI Gene 5575] {aka MASNS, PRKAR1}, PINK1 (PTEN induced kinase 1) [NCBI Gene 65018] {aka BRPK, PARK6}, PARK7 (Parkinsonism associated deglycase) [NCBI Gene 11315] {aka DJ-1, DJ1, GATD2, HEL-S-67p}
- **Diseases:** epilepsy syndrome (MESH:D000073376), spinocerebellar ataxia (MESH:D020754), toxicity (MESH:D064420), numbness (MESH:D006987), Aphasia syndrome (MESH:D001037), Hypertonia   Limb hypertonia   Lower limb hypertonia (MESH:D009122), Hypotonia (MESH:D009123), postural instability (MESH:D054972), deaths (MESH:D003643), mercury poisoning (MESH:D008630), ataxia (MESH:D001259), Rare Diseases (MESH:D035583), encephalopathy (MESH:D001927), Mental Retardation (MESH:D008607), agrammatism (MESH:D001039), and phonemic errors (MESH:D012030), PSP (MESH:D013494), Huntington disease-like 2 (MESH:C564708), movement (MESH:D009069), nervous system disorder (MESH:D009422), neurological severe disorder (MESH:D045169), Susac syndrome (MESH:D055955), abnormal speech (MESH:D013064), neuronal death (MESH:D009410), gait ataxia (MESH:D020234), dyskinesia (MESH:D004409), peripheral neuropathy (MESH:D010523), lifelong disabilities (MESH:C565569), genetic progressive disease (MESH:D018450), Parkinsonism (MESH:D010302), cerebellar hypoplasia/agenesis (MESH:C563796), dementia (MESH:D003704), neuronal intranuclear inclusion disease (MESH:C537395), Minamata Disease (MESH:D020262), neurotoxic (MESH:D020258), corticobasal syndrome (MESH:D000088282), psychiatric (MESH:D001523), X-linked spasticity (MESH:C536857), muscle weakness (MESH:D018908), cyanide poisoning (MESH:D011041), torsion dystonia (MESH:D004422), GLUT1 deficiency (MESH:C536830), Abnormality of head size (MESH:D006258), mitochondrial and lysosomal dysfunction (MESH:D016464), juvenile parkinsonism (MESH:D020734), peroxisome biogenesis disorder 9B (OMIM:614879), psychogenic movement disorders (MESH:D018781), Spasticity (MESH:D009128), Disease (MESH:D004194), Neurodegenerative dementia (MESH:D019636), metabolic, cardiovascular or immune disorders (MESH:D024821), dystonia (MESH:D004421), visual problems (MESH:D014786), mitochondrial dysfunction (MESH:D028361), Lower limb hypertonia (MESH:D038061), Parkinson disease (MESH:D010300), choreatic disease (MESH:D002819), muscle stiffness (MESH:D019042), OMIM (MESH:D030342), metabolic (MESH:D008659)
- **Chemicals:** Methylmercury (-), mercury (MESH:D008628), Cyanide (MESH:D003486), heavy metal (MESH:D019216)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** term in A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12944806/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12944806/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12944806/full.md

---
Source: https://tomesphere.com/paper/PMC12944806